1. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006; (100):S11–S15. PMID:
16612394.
Article
2. Lin YS, Fang HY, Hussein H, Fang CY, Chen YL, Hsueh SK, et al. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention. EuroIntervention. 2014; 9:1173–1180. PMID:
24561734.
3. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105:2259–2264. PMID:
12010907.
4. Azzalini L, Spagnoli V, Ly HQ. Contrast-induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol. 2016; 32:247–255. PMID:
26277092.
Article
5. Nayak KR, Mehta HS, Price MJ, Russo RJ, Stinis CT, Moses JW, et al. A novel technique for ultra-low contrast administration during angiography or intervention. Catheter Cardiovasc Interv. 2010; 75:1076–1083. PMID:
20146209.
Article
6. Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016; 37:3090–3095. PMID:
26957421.
Article
7. Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (minimizing contrast utilization with IVUS guidance in coronary angioplasty) randomized controlled trial. JACC Cardiovasc Interv. 2014; 7:1287–1293. PMID:
25326742.
8. Okumura N, Hayashi M, Imai E, Ishii H, Yoshikawa D, Yasuda Y, et al. Effects of carperitide on contrast-induced acute kidney injury with a minimum volume of contrast in chronic kidney disease patients. Nephron Extra. 2012; 2:303–310. PMID:
23341832.
Article